Literature DB >> 12629205

Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.

Anja Krones-Herzig1, Eileen Adamson, Dan Mercola.   

Abstract

The proliferation of most primary cells in culture is limited by replicative senescence and crisis, p53-dependent events. However, the regulation of p53 itself has not been defined. We find that deletion of the early growth response 1 (EGR1) transcription factor leads to a striking phenotype, including complete bypass of senescence and apparent immortal growth consistent with loss of a suppressor gene. EGR1-null mouse embryo fibroblasts (MEFs) exhibit decreased expression of p53, p21(Cip1/Waf1), and other p53 "marker" proteins. Precrisis WT but not EGR1-null cells exhibit irradiation-induced arrest. WT MEFs that emerge from crisis exhibit a mutated p53 (sequence confirmed), colony formation, and tumorigenicity. In contrast, high-passage EGR1-null MEFs retain the WT p53 sequence but with much reduced expression, remain untransformed, and grow continuously. An EGR1-expressing retrovirus restores p53 expression and sencescence to EGR1-null but not p53-null MEFs or postcrisis WT cells. Taken together, the results establish EGR1 as a major regulator of cell senescence and previously undescribed upstream "gatekeeper" of the p53 tumor suppressor pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629205      PMCID: PMC152275          DOI: 10.1073/pnas.2628034100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase.

Authors:  R Ohki; J Nemoto; H Murasawa; E Oda; J Inazawa; N Tanaka; T Taniguchi
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

Review 2.  Cellular senescence: mitotic clock or culture shock?

Authors:  C J Sherr; R A DePinho
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

Review 3.  Tumor suppressors and oncogenes in cellular senescence.

Authors:  F Bringold; M Serrano
Journal:  Exp Gerontol       Date:  2000-05       Impact factor: 4.032

4.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

5.  Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.

Authors:  C Pantoja; M Serrano
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

6.  The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251.

Authors:  C Liu; J Yao; D Mercola; E Adamson
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

Authors:  K Inoue; R Wen; J E Rehg; M Adachi; J L Cleveland; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

Review 8.  The Pezcoller lecture: cancer cell cycles revisited.

Authors:  C J Sherr
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

9.  Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Authors:  J J Jacobs; P Keblusek; E Robanus-Maandag; P Kristel; M Lingbeek; P M Nederlof; T van Welsem; M J van de Vijver; E Y Koh; G Q Daley; M van Lohuizen
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 10.  Cancer, aging and cellular senescence.

Authors:  J Campisi
Journal:  In Vivo       Date:  2000 Jan-Feb       Impact factor: 2.155

View more
  42 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Hepatic gene expression profiling of 5'-AMP-induced hypometabolism in mice.

Authors:  Zhaoyang Zhao; Takao Miki; Anita Van Oort-Jansen; Tomoko Matsumoto; David S Loose; Cheng Chi Lee
Journal:  Physiol Genomics       Date:  2011-01-11       Impact factor: 3.107

4.  Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain.

Authors:  Yifan Lu; Tong Li; Hamid Y Qureshi; Dong Han; Hemant K Paudel
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

5.  Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.

Authors:  Ashley M Ramirez-Herrick; Shannon E Mullican; Andrea M Sheehan; Orla M Conneely
Journal:  Blood       Date:  2011-01-04       Impact factor: 22.113

6.  Chlorpromazine activates p21Waf1/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells.

Authors:  Soon Young Shin; Chang Gun Kim; Se Hyun Kim; Yong Sik Kim; Yoongho Lim; Young Han Lee
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

7.  Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration.

Authors:  Tingting Li; Bingbing Wan; Jian Huang; Xuegong Zhang
Journal:  Mol Genet Genomics       Date:  2010-04-01       Impact factor: 3.291

Review 8.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

Review 9.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  Vascular gene expression in nonneoplastic and malignant brain.

Authors:  Stephen L Madden; Brian P Cook; Mariana Nacht; William D Weber; Michelle R Callahan; Yide Jiang; Michael R Dufault; Xiaoming Zhang; Wen Zhang; Jennifer Walter-Yohrling; Cecile Rouleau; Viatcheslav R Akmaev; Clarence J Wang; Xiaohong Cao; Thia B St Martin; Bruce L Roberts; Beverly A Teicher; Katherine W Klinger; Radu-Virgil Stan; Brenden Lucey; Eleanor B Carson-Walter; John Laterra; Kevin A Walter
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.